Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Established in 1988 and headquartered in Port Klang, Malaysia, Karex Berhad operates as an investment holding company primarily focused on the manufacturing and distribution of condoms. The company offers a comprehensive range of products, including personal lubricants, medical probe covers, and Foley balloon catheters utilized for transurethral urinary bladder drainage, alongside gloves. Its product portfolio has expanded to also include hand sanitizers and pre-vulcanised latex items, in addition to a wholesale service for various healthcare goods. Karex Berhad maintains a global presence, conducting business across Africa, Asia, the Americas, and Europe, serving a diverse client base that encompasses brand owners, governmental bodies, non-governmental organizations, and individual retail purchasers.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of 5247.KL is 0.60 and suggests 22.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i